Vaccine & Public Health DFnet will be attending World Vaccine Congress Washington 2026, presenting an opportunity to engage with vaccine developers, public health researchers, and sponsors who require robust clinical data management solutions for global trials.

Executive Leadership A new CEO appointed May 2025 signals potential strategic pivots or refresh strategies offering an opening for discussions on roadmaps, partnerships, and expanded service offerings aligned with growth and customer satisfaction.

Global Trials Fit With over two decades of experience in tailoring electronic data capture for global studies, DFnet targets sponsors and CROs managing multi-country trials who need scalable CDMS and data quality improvements.

Product Evolution Recent software updates such as DFdiscover 2023 Version 5.6.0 indicate ongoing product development, suggesting cross-sell or upsell opportunities for customers on legacy deployments seeking modernized features.

Midmarket Focus Revenue range and employee size place DFnet in a mid-market segment, presenting a clear path for value-focused selling around cost-effective CDMS deployments, quick setup, and flexible trial configurations.